Pfizer Inc.'s Cancer Drug Sutent Linked to Severe Skin Reactions

Published: Sep 10, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

The manufacturer of a drug used to treat several types of cancer is warning that the medication has been linked with rare but potentially fatal skin rashes. Sutent, made by Pfizer Canada Inc., is used to treat cancers of the stomach and bowels, kidney, and pancreas. In a Health Canada advisory Friday, the company said Sutent (sunitinib malate) has been associated in some people with severe skin rashes, among them Stevens-Johnson syndrome and toxic epidermal necrolysis.

Help employers find you! Check out all the jobs and post your resume.

Back to news